13F HOLDINGS REPORT
CAXTON CORP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0000919574-25-001439
Total Value
$16.6M
Positions
15
Other Managers
0
Confidential Omitted
Yes
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | XERIS BIOPHARMA HOLDINGS INC | XERS | 2,015,157 | $6.8M | 41.06% |
| 2 | REZOLUTE INC | RZLT | 1,318,967 | $6.5M | 38.85% |
| 3 | SPDR S&P 500 ETF TR | SPY | 2,823 | $1.7M | 9.94% |
| 4 | BERKSHIRE HATHAWAY INC DEL | BRK-A | 1,133 | $513,554 | 3.09% |
| 5 | SPDR GOLD TR | GLD | 1,169 | $283,068 | 1.70% |
| 6 | MIND MEDICINE MINDMED INC | 60255C885 | 34,073 | $237,149 | 1.43% |
| 7 | BICARA THERAPEUTICS INC | BCAX | 10,941 | $190,593 | 1.15% |
| 8 | LEXEO THERAPEUTICS INC | LXEO | 17,851 | $117,460 | 0.71% |
| 9 | KYVERNA THERAPEUTICS INC | KYTX | 22,981 | $85,950 | 0.52% |
| 10 | COMPASS THERAPEUTICS INC | CMPX | 43,465 | $63,025 | 0.38% |
| 11 | CARDIFF ONCOLOGY INC | CRDF | 13,287 | $57,665 | 0.35% |
| 12 | INHIBIKASE THERAPEUTICS INC | IKT | 16,393 | $53,277 | 0.32% |
| 13 | GLYCOMIMETICS INC | 38000Q102 | 203,578 | $50,895 | 0.31% |
| 14 | CONTEXT THERAPEUTICS INC | CNTX | 18,403 | $19,324 | 0.12% |
| 15 | ADICET BIO INC | ACET | 17,488 | $16,823 | 0.10% |